The effect of excess protamine on thrombelastography in vitro

Anaesthesia and Intensive Care

Volumn 34, Issue 5, 2006, Pages 579-585

  Gibbs, N M ^a   Yim, D ^a   Weightman, W ^a   Sheminant, M ^a   Rowe, R ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Anticoagulant; Coagulation; Heparin; Protamine; Thrombelastography

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANGINA PECTORIS AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENTANYL; HEPARIN; ISOFLURANE; LORAZEPAM; MIDAZOLAM; MORPHINE; PANCURONIUM; PROMETHAZINE; PROPOFOL; PROTAMINE;

ADULT; AGED; ANESTHESIA INDUCTION; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG ANTAGONISM; DRUG MONITORING; FEMALE; HEART SURGERY; HUMAN; IN VITRO STUDY; MALE; THROMBOELASTOGRAPHY;

EID: 33750607443     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0603400508     Document Type: Article

References (25)

1. Spiess BD, Tuman KJ, McCarthy RJ, DeLaria GA, Schillo R, Ivankovitch AD. Thromelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 1987; 23:25-30.
2. Dorman BH, Spinale FG, Bailey MY, Kratz JM, Roy RC. Identification of patients at risk for excessive blood loss during coronary artery bypass surgery: Thrombelastography versus coagulation screen. Anesth Analg 1993; 76:694-700.
3. Shore-Lesserson L, Manspeizer HE, Deperio M et al. Thrombelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88:312-319.
4. Metz S, Horrow JC. Pharmacological manipulation of coagulation: protamine and other heparin antagonists. In Blood: Hemostasis, Transfusion and Alternatives in the Peri-operative Period. In Lake CL, Moore RA, Eds, Raven Press Ltd, New York 1995; 118-130.
5. Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 1998; 87:781-785.
6. Mittermayr M, Margreiter J, Velik-Salchner C et al. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem®): an in vitro study. Br J Anaesth 2005; 95:310-316.
7. Horrow JC. Protamine: A review of its toxicity. Anesth Analg 1985; 64:348-361.
8. Salmenpera MT, Levy JH. Pharmacological manipulation of hemostasis. In: Blood: Hemostasis, Transfusion and Alternatives in the Peri-operative Period. Lake CL, Moore RA, Eds, Raven Press Ltd, New York 1995; 105-1179.
9. Mallett SV, Cox DJA. Thrombelastography. Br J Anaesth 1992; 69:307-313.
10. Cobel-Geard RJ, Hassouna HI. Interaction of protamine sulfate with thrombin. Am J Hematol 1983; 14:227-233.
11. Adkins Jr, Hardy JD. Sodium heparin neutralization and the anticoagulant effects of protamine sulfate. Arch Surg 1967; 94:1275-177.
12. Perkash A. A comparison of the quantitative action of protamin and heparin on blood coagulation. Am J Clin Path 1979; 77:676-681.
13. Ellison N, Ominsky AJ, Wollman H. Is protamine a clinically important anticoagulant? A negative answer. Anesthesiology 1971; 35:621-629.
14. Ellison N, Edmunds LH, Colman RW. Platelet aggregation following heparin and protamine administration. Anesthesiology 1978; 48:65-68.
15. Lindblad B, Wakefield TW, Whitehouse WM Jr, Stanley JC. The effect of protamine on platelet function. Scand J Thor Cardiovasc Surg 1988; 22:55-59.
16. Ammar T. The effects of heparinase 1 and protamine on platelet reactivity. Anesthesiology 1997; 86:1382-1386.
17. Gottumukkala VNR, Sharma SK, Philip J. Assessing platelet and fibrinogen contribution to clot strength using modified thromboelastography in pregnant women. Anesth Analg 1999; 89:1453-1457.
18. Bowbrick VA, Mikhailidis DP, Stansby G. Value of thrombelastography in the assessment of platelet function. Clin Appl Thromb Hemost 2003; 9:137-142.
19. Samama CM. Thrombelastography: The next step. Anesth Analg 2001; 92:563-564.
20. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery. Anesthesiology 1999; 91:1122-1151.
21. Tanaka KA. Szlam F. Kelly AB. Vega JD. Levy JH. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding. Platelets 2004; 15:325-332.
22. Tuman KJ, McCarthy RJ, Djuric M, Rizzo V, Ivankovich AD. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thrombelastographic assay. J Cardiothor Vasc Anesth 1994; 8:144-149.
23. Despotis GJ, Summerfield AL, Joist JH et al. In vitro reversal of heparin effect with heparinase: Evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients. Anesth Analg 1994; 79:670-674.
24. Spiess BD, Wall MH, Gillies BS, Fitch JCK, Soltow LO, Chandler WL. A comparison of thrombelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass. Thromb Haemost 1997; 78:820-826.
25. Butterworth J, Lin YA, Prielipp RC, Bennett J, Hammon JW, James RL. Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass. Ann Thorac Surg 2002; 74:1589-1595.